Product
HS-10516
1 clinical trial
1 indication
Indication
Renal Cell CarcinomaClinical trial
A Phase Ia/Ib Study of HS-10516 to Investigate the Safety, Tolerance, Pharmacokinetic and Efficacy in Patients With Advanced Clear Cell Renal Cell CarcinomaStatus: Not yet recruiting, Estimated PCD: 2024-09-25